LUTS, nocturia

Question 1

nocturia

definition

Answer 1

.

Question 2

polyuria

definition

Answer 2

.

Question 3

nocturia index

nocturnal polyuria index
definitions

Answer 3

.

Question 4

what is ADH

Answer 4

aquaporins

Question 5

Tea time Lasix in nocturia

efficacy

Answer 5

mean reduction 0.5
reduction of at least 1 episode 37%
NUCV reduces 18%

Question 6

nocturia

a blocker efficacy

Answer 6

similar to Lasix

Veterans study

Question 7

nocturia

anti cholinergics efficacy

Answer 7

reduction < 0.5

MA

Question 8

what is DDAVP and its efficacy

Answer 8

V2

Question 9

CI to DDAVP

Answer 9

.

Question 10

SE OF DDAVP

Answer 10

.

Question 11

what is BPH

Answer 11

Cunha

Question 12

How common is BPH in autopsy series?

Answer 12

88% in 80s

Question 13

How common is BPH in Asian men?

Answer 13

60s 40%

Question 14

What is IPSS?

Answer 14

7 symptoms  (0 - 35)
1 QoL

Question 15

How many patients have BOO when Qmax < 10

How many Qmax < 10 have BOO

Answer 15

70% (ICS-BPH study)

53%

Question 16

what is intravesical prostatic protrusion and cutoff?

Answer 16

150 - 250ml

PPV 94%

Question 17

Natural hx of BPH

VA / OCS / MTOPS

Answer 17

.

Question 18

Forms of clinical progression

Answer 18

MTOPS

Question 19

Predictors of BPH progression

Answer 19

.

Question 20

Relationship between LUTS and vascular diseases

Study = ?

Answer 20

MSAM-7

Question 21

Physiology of UUO and BUO
Timing
Molecules involved

Answer 21

0 - 90min (PGE2, NO)
90min - 5h
> 5h (TXA2)

Question 22

Time for recovery after obstruction
Tubular fx
Glomerular fx

Answer 22

14d

3m

Question 23

WW for LUTS
Components =?
Efficacy =?

Answer 23

CONDUCT: IPSS 5 - 6

Question 24

a-blocker in BPH:

Efficacy

Answer 24

IPSS 4

Qmax 3

Question 25

ALLHAT study
Risk of combined CVD events : ___
Risk of CHF: ___
Risks of all-cause mortality: ___

Answer 25

25%
2X
NO

Question 26

5ARI for BPH : Efficacy:
IPSS
Qmax

Answer 26

IPSS 5 - 6

Qmax 2

Question 27

what is PLESS?

Answer 27

RRR 55% for AUR / BPH OT

Question 28

SE of 5ARI
Redcued libido: _
ED: _
Depression: _
Gynecomastia: _

Answer 28

6%
8%
10% higher
1%

Question 29

MTOPS results
IPSS: _
Qmax: _
AUR: _
OT: _
Clinical progression: _

Answer 29

7
4
81%
67%
66%

Question 30

Efficacy of PDE5i on BPH

Answer 30

IPSS 3 , IIEF

McVary

Question 31

Prostamol component and efficacy

Answer 31

Saw palmetto

Qmax

Question 32

HoLEP
Fiber size
Energy setting

Answer 32

550um

2J 50Hz

Question 33

HoLEP
Transfusion rate
Re-op rate

Answer 33

0. 8%

0. 7% at 10y

Question 34

Mechanism of PVP

Answer 34

YAG, LBO
600um , side-firing
oxy-Hb
poor absorption by water

Question 35

what is the power of MoXy fiber?

Answer 35

180W

Question 36

UK-ROPE study for PAE: results
IPSS
Re-tx

Answer 36

10 points at 12m

5% at 1y, overall 20%

Question 37

Components of Urolift

Answer 37

3

Question 38

Rezum:

Each __second treatment delivers __ml water vapour

Answer 38

9s

0.42ml

Question 39

what is Memokath

Answer 39

nickel-titanium alloy

Question 40

what is iTIND?

Answer 40

nitinol; butterfly-like

Question 41

what is TUR syndrome

Answer 41

5

Question 42

Glycine 1.5%
Osmolality: _
Absorption rate: _

Answer 42

200mOsm/L

20ml/min